Z. Xu, M. Flavin, and J. Flavin, Combating multidrug-resistant Gram-negative bacterial infections, Expert Opinion on Investigational Drugs, vol.48, issue.8, pp.163-82, 2014.
DOI : 10.1038/nm0711-772

I. Karaiskos and H. Giamarellou, Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches, Expert Opinion on Pharmacotherapy, vol.29, issue.10, p.24766095, 2014.
DOI : 10.1185/03007995.2012.748653
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819585

M. Bassetti, M. Merelli, C. Temperoni, and A. Astilean, New antibiotics for bad bugs: where are we?, Annals of Clinical Microbiology and Antimicrobials, vol.12, issue.1, pp.22-32, 2013.
DOI : 10.1128/AAC.02106-12

G. Cox and G. Wright, Intrinsic antibiotic resistance: Mechanisms, origins, challenges and solutions, International Journal of Medical Microbiology, vol.303, issue.6-7, pp.6-7, 2013.
DOI : 10.1016/j.ijmm.2013.02.009

A. Davin-regli, J. Bolla, C. James, J. Lavigne, C. J. Garnotel et al., Membrane Permeability and Regulation of Drug “Influx and Efflux” in Enterobacterial Pathogens, Current Drug Targets, vol.9, issue.9, pp.750-759, 2008.
DOI : 10.2174/138945008785747824

H. Schweizer, Understanding efflux in Gram-negative bacteria: opportunities for drug discovery, Expert Opinion on Drug Discovery, vol.43, issue.6, pp.633-675, 2012.
DOI : 10.1067/mic.2003.11

J. Pagès, C. James, and M. Winterhalter, The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria, Nature Reviews Microbiology, vol.390, issue.12, pp.893-903, 2008.
DOI : 10.1016/S0969-2126(99)80055-0

Y. Morita, J. Tomida, and Y. Kawamura, Responses of Pseudomonas aeruginosa to antimicrobials, Frontiers in Microbiology, vol.4, 2014.
DOI : 10.3389/fmicb.2013.00422

L. Mamelli, S. Petit, C. J. Giglione, C. Lieutaud, A. Meinnel et al., New Antibiotic Molecules: Bypassing the Membrane Barrier of Gram Negative Bacteria Increases the Activity of Peptide Deformylase Inhibitors, PLoS ONE, vol.3, issue.7, 2009.
DOI : 10.1371/journal.pone.0006443.t005
URL : https://hal.archives-ouvertes.fr/hal-00853795

D. Livermore, Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?, Clinical Infectious Diseases, vol.34, issue.5, pp.634-674, 2002.
DOI : 10.1086/338782

K. Okamoto, N. Gotoh, and T. Nishino, Extrusion of Penem Antibiotics by Multicomponent Efflux Systems MexAB-OprM, MexCD-OprJ, and MexXY-OprM of Pseudomonas aeruginosa, Antimicrobial Agents and Chemotherapy, vol.46, issue.8, pp.2696-2705, 2002.
DOI : 10.1128/AAC.46.8.2696-2699.2002

Y. Morita, J. Tomida, and Y. Kawamura, MexXY multidrug efflux system of Pseudomonas aeruginosa, Frontiers in Microbiology, vol.3, p.23233851, 2012.
DOI : 10.3389/fmicb.2012.00408

N. Masuda, E. Sakagawa, S. Ohya, N. Gotoh, H. Tsujimoto et al., Substrate Specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM Efflux Pumps in Pseudomonas aeruginosa, Antimicrobial Agents and Chemotherapy, vol.44, issue.12, pp.3322-3329, 2000.
DOI : 10.1128/AAC.44.12.3322-3327.2000

D. Hocquet, M. Roussel-delvallez, J. Cavallo, and P. Plésiat, MexAB-OprM- and MexXY-Overproducing Mutants Are Very Prevalent among Clinical Strains of Pseudomonas aeruginosa with Reduced Susceptibility to Ticarcillin, Antimicrobial Agents and Chemotherapy, vol.51, issue.4, pp.1582-1585, 2007.
DOI : 10.1128/AAC.01334-06
URL : https://hal.archives-ouvertes.fr/hal-00464782

X. Li, H. Nikaido, and K. Poole, Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa, Antimicrobial Agents and Chemotherapy, vol.39, issue.9, pp.1948-53, 1995.
DOI : 10.1128/AAC.39.9.1948

N. Masuda, E. Sakagawa, S. Ohya, N. Gotoh, H. Tsujimoto et al., Contribution of the MexX-MexY-OprM Efflux System to Intrinsic Resistance in Pseudomonas aeruginosa, Antimicrobial Agents and Chemotherapy, vol.44, issue.9, pp.2242-2248, 2000.
DOI : 10.1128/AAC.44.9.2242-2246.2000

J. Brunel, A. Lieutaud, V. Lome, J. Pagès, and J. Bolla, Polyamino geranic derivatives as new chemosensitizers to combat antibiotic resistant Gram-negative bacteria, Bioorganic & Medicinal Chemistry, vol.21, issue.5, pp.1174-1179, 2013.
DOI : 10.1016/j.bmc.2012.12.030

J. Bolla, J. Brunel, J. Casanova, V. Lorenzi, and L. Berti, Preparation of polyaminoisoprenyl derivatives for use in medical and nonmedical antibiotic or antiseptic treatment, PCT Int Appl, p.51, 2012.

A. Lieutaud, E. Guinoiseau, V. Lorenzi, M. Guiliani, V. Lome et al., Inhibitors of Antibiotic Efflux by AcrAB-TolC in Enterobacter aerogenes, Anti-Infective Agents, vol.11, issue.2, pp.168-178, 2013.
DOI : 10.2174/2211352511311020011
URL : https://hal.archives-ouvertes.fr/hal-00798272

C. Stover, X. Pham, A. Erwin, S. Mizoguchi, P. Warrener et al., Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen, Nature, vol.406, issue.6799, pp.959-64, 2000.

J. Dumas, C. Van-delden, K. Perron, and T. Köhler, by quantitative real-time-PCR, FEMS Microbiology Letters, vol.254, issue.2, pp.217-242, 2006.
DOI : 10.1111/j.1574-6968.2005.00008.x

M. Hamzehpour, J. Pechere, P. Plésiat, and T. Köhler, OprK and OprM define two genetically distinct multidrug efflux systems in Pseudomonas aeruginosa, Antimicrobial Agents and Chemotherapy, vol.39, issue.11, pp.2392-2398, 1995.
DOI : 10.1128/AAC.39.11.2392

T. Köhler, M. Michea-hamzehpour, U. Henze, N. Gotoh, L. Curty et al., Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa, Molecular Microbiology, vol.23, issue.2, pp.345-54, 1997.
DOI : 10.1046/j.1365-2958.1997.2281594.x

C. Muller, P. Plésiat, and K. Jeannot, A Two-Component Regulatory System Interconnects Resistance to Polymyxins, Aminoglycosides, Fluoroquinolones, and ??-Lactams in Pseudomonas aeruginosa, Antimicrobial Agents and Chemotherapy, vol.55, issue.3, pp.1211-1232, 2011.
DOI : 10.1128/AAC.01252-10

L. Vettoretti, P. Plésiat, C. Muller, G. El, F. Phan et al., Efflux Unbalance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients, Antimicrobial Agents and Chemotherapy, vol.53, issue.5, pp.1987-97, 2009.
DOI : 10.1128/AAC.01024-08
URL : https://hal.archives-ouvertes.fr/hal-00496238

F. Odds, Synergy, antagonism, and what the chequerboard puts between them, Journal of Antimicrobial Chemotherapy, vol.52, issue.1, p.12805255, 2003.
DOI : 10.1093/jac/dkg301

K. Agwuh and A. Macgowan, Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines, Journal of Antimicrobial Chemotherapy, vol.58, issue.2, pp.256-65, 2006.
DOI : 10.1093/jac/dkl224

H. Taber, J. Mueller, P. Miller, and A. Arrow, Bacterial uptake of aminoglycoside antibiotics, Microbiol Rev, vol.51, issue.4, pp.439-57, 1987.

T. Renau, R. Léger, L. Filonova, E. Flamme, M. Wang et al., Conformationally-restricted analogues of efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa, Bioorganic & Medicinal Chemistry Letters, vol.13, issue.16, pp.2755-2763, 2003.
DOI : 10.1016/S0960-894X(03)00556-0

O. Lomovskaya, M. Warren, A. Lee, J. Galazzo, R. Fronko et al., Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa: Novel Agents for Combination Therapy, Antimicrobial Agents and Chemotherapy, vol.45, issue.1, pp.105-121, 2001.
DOI : 10.1128/AAC.45.1.105-116.2001

K. Poole, Pseudomonas Aeruginosa: Resistance to the Max, Frontiers in Microbiology, vol.2, p.21747788, 2011.
DOI : 10.3389/fmicb.2011.00065

R. Iino, K. Nishino, H. Noji, A. Yamaguchi, and Y. Matsumoto, A Microfluidic Device for Simple and Rapid Evaluation of Multidrug Efflux Pump Inhibitors, Frontiers in Microbiology, vol.3, 2012.
DOI : 10.3389/fmicb.2012.00040

R. Lamers, J. Cavallari, and L. Burrows, The Efflux Inhibitor Phenylalanine-Arginine Beta-Naphthylamide (PA??N) Permeabilizes the Outer Membrane of Gram-Negative Bacteria, PLoS ONE, vol.1, issue.3, pp.60666-60672, 2012.
DOI : 10.1371/journal.pone.0060666.s001

D. Kwon and C. Lu, Polyamines Increase Antibiotic Susceptibility in Pseudomonas aeruginosa, Antimicrobial Agents and Chemotherapy, vol.50, issue.5, pp.1623-1630, 2006.
DOI : 10.1128/AAC.50.5.1623-1627.2006

A. Verchère, I. Broutin, and M. Picard, Photo-induced proton gradients for the in vitro investigation of bacterial efflux pumps. Sci Rep, pp.10-00306, 1038.

L. Ejim, M. Farha, S. Falconer, J. Wildenhain, B. Coombes et al., Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy, Nature Chemical Biology, vol.51, issue.6, pp.348-50, 2011.
DOI : 10.1038/nchembio.559

B. Bell, F. Schellevis, E. Stobberingh, H. Goossens, and M. Pringle, A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance, BMC Infectious Diseases, vol.16, issue.10, p.24405683, 2014.
DOI : 10.1016/S0169-5347(01)02235-2

O. Nitzan, U. Suponitzky, Y. Kennes, B. Chazan, R. R. Colodner et al., Is chloramphenicol Making a comeback, Isr Med Assoc J, vol.12, issue.6, pp.371-375, 2010.

M. Butler, M. Blaskovich, and M. Cooper, Antibiotics in the clinical pipeline in 2013, The Journal of Antibiotics, vol.42, issue.10, pp.571-91, 2013.
DOI : 10.2174/138945012799424624